TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside of the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ retrieval, OCS organ management and logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation, ground transportation and other coordination activity. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
äŒæ¥ã³ãŒãTMDX
äŒç€ŸåTransmedics Group Inc
äžå Žæ¥May 02, 2019
æé«çµå¶è²¬ä»»è
ãCEOãDr. Waleed H. Hassanein, M.D.
åŸæ¥å¡æ°728
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«May 02
æ¬ç€Ÿæåšå°200 Minuteman Road
éœåžANDOVER
蚌åžååŒæNASDAQ Global Market Consolidated
åœUnited States of America
éµäŸ¿çªå·01810
é»è©±çªå·19785520900
ãŠã§ããµã€ãhttps://www.transmedics.com/
äŒæ¥ã³ãŒãTMDX
äžå Žæ¥May 02, 2019
æé«çµå¶è²¬ä»»è
ãCEOãDr. Waleed H. Hassanein, M.D.
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã